Annegien Broeks

12PUBLICATIONS
161CO-AUTHORS
Predictive and prognostic markersMicrobial ecologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 17, 2026
Pre-existing immunity and hrHPV status determine immunotherapy response in advanced penile cancer: biomarkers and overall survival in the PERICLES trial.

|Sep 25, 2025
Microbial Metabolic Pathways Guide Response to Immune Checkpoint Blockade Therapy.

Iris L Mimpen, Thomas W Battaglia, Miguel Parra-Martinez

|Jun 09, 2025
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study.

Chantal F Stockem, Alberto Gil-Jimenez, Hamza Ali

|Jul 24, 2024
Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer Microenvironment.

Maksim A Chelushkin, Jeroen van Dorp, Sandra van Wilpe

|May 15, 2024
Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.

Birgit S Geurts, Laurien J Zeverijn, Jade M van Berge Henegouwen

|Oct 03, 2023
International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy.

Carine El Sissy, Amos Kirilovsky, Christine Lagorce Pagès

Pageof 2

Frequent Collaborators

5 joint publications

Lodewyk Wessels

5 joint publications

Erik Hooijberg

5 joint publications

Dennis Peters

4 joint publications

Alberto Gil-Jimenez